Zobrazeno 1 - 10
of 324
pro vyhledávání: '"Denis, Smith"'
Autor:
Pascal Hammel, Denis Smith, Pauline Afchain, Sophie Dominguez-Tinajero, Jean-François Seitz, Astrid Lievre, Eric Van Cutsem, Eric Assenat, Frédéric Di Fiore, Marc Peeters, Iradj Sobhani, Eric Raymond, Emilie Charton, Dewi Vernerey, Louis De Mestier, Catherine Lombard-Bohas
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 16 (2024)
Background: Sunitinib, a multitarget tyrosine kinase inhibitor, showed encouraging antitumor activity and manageable toxicity in patients with advanced midgut neuroendocrine tumors (NETs) in earlier results from phase I and II trials. Patients and me
Externí odkaz:
https://doaj.org/article/ebe96611089f44d087d3bcf611331015
Autor:
Stefano Kim, Véronique Vendrely, Angélique Saint, Thierry André, Pauline Vaflard, Emmanuelle Samalin, Simon Pernot, Oliver Bouché, Mustapha Zubir, Jérôme Desrame, Christelle de la Fouchardière, Denis Smith, François Ghiringhelli, Angélique Vienot, Marion Jacquin, Elodie Klajer, Thierry Nguyen, Éric François, Julien Taieb, Karine Le Malicot, Dewi Vernerey, Aurélia Meurisse, Christophe Borg
Publikováno v:
Experimental Hematology & Oncology, Vol 12, Iss 1, Pp 1-5 (2023)
Abstract Triplet DCF (docetaxel, cisplatin and 5-flurouracil) and doublet CP/CF (carboplatin and paclitaxel/cisplatin and 5-fluorouracil) regimens were prospectively evaluated in advanced squamous anal cell carcinoma (SCCA), and validated as standard
Externí odkaz:
https://doaj.org/article/e56120f3ba0e48b2bc81859d07428c3b
Autor:
Eugénie Rigault, Benjamin Lacas, Olivier Glehen, Denis Smith, Eric Dupont-Bierre, Rosine Guimbaud, David Malka, Valérie Boige, Alina Fuerea, Jean-Pierre Pignon, Michel Ducreux
Publikováno v:
Cancer Treatment and Research Communications, Vol 34, Iss , Pp 100674- (2023)
Introduction: Intra-arterial hepatic (IAH) treatment has shown promising results in the management of patients with unresectable colorectal liver metastases (CRLM) the prognosis of which is poor. Bevacizumab adjunction to standard chemotherapy has be
Externí odkaz:
https://doaj.org/article/c22bcb3444d34782a25dee5d64cfa6c8
Autor:
Violaine Randrian, Simon Pernot, Baptiste Sionneau, Denis Smith, Annie Lim, Yann Touchefeu, Claire Gallois, Anthony Turpin, Sahir Javed, Rosine Guimbaud, Pascale Rivera, Mehdi Karoui, Edouard Auclin, Julien Taieb
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
BackgroundHepatic arterial infusion (HAI) of chemotherapy is an option for the treatment of patients with liver metastases from colorectal cancer (LMCRC). Though HAI with oxaliplatin (HAI-Ox) is generally used, intravenous (IV) 5-fluoro-uracil (5FU)-
Externí odkaz:
https://doaj.org/article/3d38b7e1590d418bb1ae1cbc9f479ef2
Autor:
Stefano Kim, Bruno Buecher, Thierry André, Marine Jary, François-Clément Bidard, François Ghiringhelli, Éric François, Julien Taieb, Denis Smith, Christelle de la Fouchardière, Jérôme Desramé, Emmanuelle Samalin, Aurélie Parzy, Nabil Baba-Hamed, Olivier Bouché, David Tougeron, Laëtitia Dahan, Farid El Hajbi, Marion Jacquin, Magali Rebucci-Peixoto, Laurie Spehner, Véronique Vendrely, Dewi Vernerey, Christophe Borg
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background Modified docetaxel, cisplatin, and 5-fluorouracil (mDCF) regimen has become a new standard for the treatment of metastatic or unresectable locally advanced recurrent squamous cell carcinoma of the anus (SCCA) after demonstrating i
Externí odkaz:
https://doaj.org/article/07cff244a8334a279f68769e303b762a
Autor:
Denis-Smith, John, author
Publikováno v:
Wilmot-Smith on Construction Contracts, 2021.
Externí odkaz:
https://doi.org/10.1093/oso/9780198832805.003.0002
Autor:
Denis-Smith, John, author, Hurst, Peter, author
Publikováno v:
Wilmot-Smith on Construction Contracts, 2021.
Externí odkaz:
https://doi.org/10.1093/oso/9780198832805.003.0021
Autor:
Hyun Cheol Chung, Hendrik-Tobias Arkenau, Jeeyun Lee, Sun Young Rha, Do-Youn Oh, Lucjan Wyrwicz, Yoon-Koo Kang, Keun-Wook Lee, Jeffrey R. Infante, Sung Sook Lee, Margaret Kemeny, Ulrich Keilholz, Bohuslav Melichar, Alain Mita, Ruth Plummer, Denis Smith, Arnold B. Gelb, Huiling Xiong, Janet Hong, Vikram Chand, Howard Safran
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-10 (2019)
Abstract Background We evaluated the antitumor activity and safety of avelumab, a human anti–PD-L1 IgG1 antibody, as first-line switch-maintenance (1 L-mn) or second-line (2 L) treatment in patients with advanced gastric/gastroesophageal cancer (GC
Externí odkaz:
https://doaj.org/article/22a26bd6feb14e4185d7a995dfe688b6
Autor:
Thomas Walter, Astrid Lievre, Romain Coriat, David Malka, Farid Elhajbi, Fréderic Di Fiore, Olivia Hentic, Denis Smith, Vincent Hautefeuille, Guillaume Roquin, Marine Perrier, Laetitia Dahan, Victoire Granger, Iradj Sobhani, Laurent Mineur, Patricia Niccoli, Eric Assenat, Jean-Yves Scoazec, Karine Le Malicot, Côme Lepage, Catherine Lombard-Bohas
Publikováno v:
The Lancet Oncology. 24:297-306
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a69b627c0c87a564ed0924d8ac89526
https://doi.org/10.1016/s1470-2045(23)00001-3
https://doi.org/10.1016/s1470-2045(23)00001-3
Autor:
Côme Lepage, Jean-Marc Phelip, Astrid Lievre, Karine Le-Malicot, Laetitia Dahan, David Tougeron, Christos Toumpanakis, Frédéric Di-Fiore, Catherine Lombard-Bohas, Ivan Borbath, Romain Coriat, Thierry Lecomte, Rosine Guimbaud, Caroline Petorin, Jean-Louis Legoux, Pierre Michel, Jean-Yves Scoazec, Denis Smith, Thomas Walter
Publikováno v:
European Journal of Cancer
European Journal of Cancer, 2022, 175, pp.31-40. ⟨10.1016/j.ejca.2022.07.033⟩
European Journal of Cancer, 2022, 175, pp.31-40. ⟨10.1016/j.ejca.2022.07.033⟩
International audience; Background: Following European guidelines, patients with aggressive metastatic or locally advanced, non-resectable, duodeno-pancreatic (DP) neuroendocrine tumours (NETs) should receive systemic combination chemotherapy until p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::741d2d1e2010a09aa7ef527afc47495e
https://doi.org/10.1016/j.ejca.2022.07.033
https://doi.org/10.1016/j.ejca.2022.07.033